Select display options below. (Cookies need to be enabled in your browser!)
Colors: High contrast    Default    Font Size: X-Large    Large    Medium    Default    Small   
 
 
Research & Clinical Trials

Study Detail: Angioid Streaks

Trial Description

Summary : to compare the effectiveness of Macugen to Photodynamic Laser Therapy (PDT) to prevent vision loss from abnormal blood vessels in the eye (CNV) from angioid streaks & other uncommon conditions complicated by CNV

Basic Trial Information
PhaseDiseaseStatusAgeSponsorProtocol #
NASubfoveal CNV secondary to Angioid Streaksenrolling> 18 yrsEyetechNA
Study Duration: 54 weeksEligibility Criteria:Inclusion Criteria
  • Included conditions: ocular histoplasmosis,multifocal choroiditis, birdshot choroiditis, serpiginous/helicoid choroidopathy, choroidal rupture, choroidal osteoma, idiopathic CNV, Best’s vitelliform dystrophy, fundus flavimaculatus, choroideremia, rubella retinopathy, toxocara canis, ocular toxoplasmosis, sarcoidosis, Harada’s disease, choroidal melanocytic nevus, optic nerve drusen, CNV complicating thermal laser treatment, blunt trauma  
  • Angioid Streaks of any etiology with secondary subfoveal CNV
  • SE best correction of 20/40 or worse
  • Check with study coordinator for other study inclusion criteria
 Exclusion Criteria
  • More than 1 previous PDT treatment
  • PDT treatment done within 3 months- must wait to enroll after the 3 month period
  • Check with study coordinator for other study exclusion criteria
 Study Title : EYETECH MACUGEN for ANGIOID STREAKS and Other Uncommon Conditions Complicated by Choroidal Neovascular MembranesTrial Contact Information
SiteStudy Coordinator
Beachwood

Vivian 216/831-5704 ext. 253

Lakewood

Susan R. 216/831-5704 ext 253

Youngstown

Tami H. 216/831-5704 ext. 253